The Literature

» physiology and developmental biology

Most Recent

image: An Eyeful of RNA

An Eyeful of RNA

By | August 1, 2011

Editor's Choice in Physiology

3 Comments

image: A Joint Endeavor

A Joint Endeavor

By | June 14, 2011

Editor's selection in physiology

0 Comments

image: The Axis of Aging

The Axis of Aging

By | June 14, 2011

Editor's choice in developmental biology

0 Comments

image: Hangover Headache

Hangover Headache

By | May 25, 2011

Editor's choice in neuroscience

0 Comments

image: Control from Without

Control from Without

By | May 25, 2011

Editor's Choice in Developmental Biology

0 Comments

image: Model Liver

Model Liver

By | April 1, 2011

Editor's choice in physiology

0 Comments

image: The Footprints of Winter

The Footprints of Winter

By | March 1, 2011

Epigenetic marks laid down during the cold months of the year allow flowering in spring and summer.

0 Comments

image: Bitter Pill

Bitter Pill

By | March 1, 2011

Editor's choice in drug discovery

0 Comments

image: Calcium Kicks

Calcium Kicks

By | March 1, 2011

Editor's choice in physiology

0 Comments

image: When Stress Is Good

When Stress Is Good

By | February 1, 2011

Fast blood flow protects against atherosclerosis: implications for treatment

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham